Introduction
The growth of hormone-dependent breast and prostate carcinomas is regulated through signal transduction pathways involving estrogen receptor (ER) and androgen receptor (AR), respectively, both of which belong to the nuclear receptor superfamily (Mangelsdorf et al., 1995) . Although hormone-dependent cancer growth has been investigated extensively, the molecular mechanism of hormone dependence is not fully understood (Henderson et al., 1993; Goldhirsch and Gelber, 1996) . Since growth signals through nuclear receptors must ultimately aect the cell cycle machinery, recently attention has focused on a link between nuclear hormone receptors and cell cycle regulation .
Cell cycle progression is governed by successive, coordinated activation of cyclin-dependent kinases (Cdks), whose activities are regulated positively by cyclin subunits and negatively by Cdk inhibitors (CKIs) (Morgan, 1995) . During progression through the G1 phase of the cell cycle, D-type cyclins interacting with Cdk4 and 6 and cyclin E interacting with Cdk2 play a central role (Sherr, 1993) . In mammalian cells, two distinct families of CKIs have been identi®ed; the Cip/Kip family, represented by p21
Waf1/Cip1/Sdi1 , p27 Kip1 and p57 kip2 , inhibits a wide range of cyclin/Cdk complexes while the INK4 family, such as p15 INK4b , p16 INK4a , p18
INK4c and p19
INK4d
, speci®cally inhibits cyclin D/Cdk4 and Cdk6 (Sherr and Roberts, 1995) . These regulators play an important role in the proliferation of normal cells. Functional activation of positive regulators and inactivation of negative regulators, most notably deletion of the p16
INK4a gene, are also implicated in carcinogenesis (Serrano et al., 1996) .
Ampli®cation and overexpression of the cyclin D1 gene occurs in some breast cancer patients (Buckley et al., 1993; Keyomarsi and Pardee, 1993) . Cyclin D1 seems to be a major target of ER, since estrogen directly activates the transcription of the cyclin D1 gene in hormone-responsive breast carcinoma (Altucci et al., 1996) and antiestrogens reduce cyclin D1 levels, thereby causing growth suppression (Watts et al., 1995) . Recently, Planas-Silva and Weinberg proposed a model of cyclin D1-mediated p21
Waf1/Cip1/Sdi1 redistribution from cyclin E/Cdk2 to cyclin D1/Cdk4 in the activation of Cdk2 complexes by estrogen (Planas-Silva and Weinberg, 1997) . Furthermore, biochemical evidence for the activation of ER through direct interaction with cyclin D1 in the absence of estrogen has provided a novel mechanism for hormoneindependent growth of breast cancer (Zwijsen et al., 1997; Neuman et al., 1997) .
In contrast, very little is known about the molecular mechanism of androgen-regulated cancer growth, and there have been few reports on the link between a signaling pathway through AR and the cell cycle machinery (Lu et al., 1997) . Recently, Klein et al. demonstrated that tumors from advanced, hormoneindependent prostate cancer patients, when grown in SCID mice, recapitulate the clinical feature of progression from androgen-sensitive to androgenindependent growth (Klein et al., 1997) , suggesting that some dysfunction in the cellular response to changes in hormonal environment rather than genetic mutations in AR may play an important role in the progression of the disease. Therefore, clarifying the initial response of the cell cycle machinery in cancer cells to androgen depletion would seem to be important for understanding dysfunctions that occur during treatment with anti-androgen drugs and lead to the development of resistance to endocrine therapy.
In order to address this issue, in the present study we characterized the functional and quantitative alterations in positive and negative regulators of the cell cycle following hormone withdrawal, using an androgen-dependent cancer cell line (SC-3) established from Shionogi mouse mammary carcinoma (Minesita and Yamaguchi, 1965) . Shionogi tumors grow rapidly in the presence of androgen, regress when androgen is withdrawn, and fail to grow in female host (Minesita and Yamaguchi, 1965) . The tumor contains AR and has maintained androgen dependency both in vivo and in vitro for many generations, which makes it an attractive model for studying androgenregulated cancer cell growth. We used SC-3 cells, a highly androgen-sensitive subline of Shionogi carcinoma (Noguchi et al., 1987) , in the current investigation. Androgen-dependent nature of SC-3 cell growth has been well characterized, and an androgen-induced growth factor has been puri®ed from the conditioned medium and molecularly cloned (Tanaka et al., 1992) .
In the current study we focused on changes in the cell cycle apparatus when the hormonal environment was changed from a replete to a depleted state, whereas most previous studies on hormone-responsive tumors, mainly breast cancer, analysed cellular events during synchronous growth stimulation by estrogen after cell cycle arrest Planas-Silva and Weinberg, 1997) . The results suggest that p27
Kip1 CKI is induced after androgen depletion and plays a pivotal role in G1 arrest by markedly inhibiting Cdk2 activity through association with the kinase complex.
Results
Characterization of androgen-dependent cell cycle progression in SC-3 cells SC-3 cells which were maintained in medium supplemented with serum and testosterone were cultured in serum-free medium in the presence or absence of 10 77 M testosterone, and the eect of androgen depletion on cell proliferation was determined for 7 days. The results of a representative experiment are shown in Figure 1 . SC-3 cells grew exponentially in the presence of testosterone, whereas cell proliferation was almost completely absent without the hormone. A signi®cant decrease in cell proliferation was observed as early as 72 h after androgen depletion. Dihydrotestosterone, a non-aromatizable androgen, as well as testosterone stimulated the proliferation of SC-3 cells in a dose-dependent manner, which was inhibited by¯utamide (data not shown). Estrogen had only a minimum eect on the proliferation of SC-3 cells as previously reported (Noguchi et al., 1987) , and treatment with 10 77 M 17b-estradiol for 7 days increased the cell number only twofold more than cells without estradiol (data not shown), as opposed to nearly 100-fold by testosterone (Figure 1 ). Taken together with the presence of AR in SC-3 cells (Noguchi et al., 1987; Menjo et al., unpublished observations) , it is suggested that androgens stimulate the growth of SC-3 cells through AR.
FACS analysis showed that androgen-depleted SC-3 cells were arrested in the G1 phase of the cell cycle (Figure 2 ). The proportion of cells in G0/G1 increased from 43 to 69%, and that in S phase decreased from 46 to 13% after 72 h of hormone withdrawal. In the presence of 10 77 M testosterone, SC-3 cells continued to progress through the cycle. These results suggest that the growth suppression of SC-3 cells following androgen depletion is at least in part due to G1 arrest.
Suppression of cyclin D1/Cdk4 activity does not precede G1 arrest following androgen depletion
We next examined the eects of androgen withdrawal on the activities of cyclin/Cdk complexes which play a pivotal role in the progression from G1 to S phase of the cell cycle. Since the cyclin D1/Cdk4 complex has been implicated in estrogen-induced breast cancer cell growth (Planas-Silva and Weinberg, 1997; Prall et al., 1997) , we ®rst focused on determining the alterations in cyclin D1/Cdk4 activities following androgen depletion Figure 1 Growth suppression after testosterone depletion in SC-3 cells. After being plated at 2610 3 /cm 2 in the maintenance medium (described in Materials and methods), SC-3 cells were refed with serum-free DMEM/F12 with 0.1% BSA and 10 77 M testosterone on the following day. Two days later (day 0), the medium was changed to serum-free DMEM/F12 with (closed circles) or without (open circles) 10 77 M testosterone, and the medium was changed every 48 h thereafter. The number of viable cells was counted by trypan blue exclusion using a hemocytometer. Data are shown as mean of the triplicate dishes. No error bars are shown because variation is too low for visual display. ***; P50.005 vs cells without testosterone at the same time points (by Student's t-test) of SC-3 cells. Cell lysates were immunoprecipitated with anti-cyclin D1 or anti-Cdk4 antibody, and kinase activities were determined based on the phosphorylation of GST-Rb protein. As reported previously (Matsushime et al., 1994) , phosphorylated GST-Rb was detected as a single band on SDS-polyacrylamide gels. As shown in Figure 3a , the activity of Cdk4 did not change appreciably 24 h after hormone withdrawal, but did decrease progressively at 48 and 72 h, compared with the kinase activity in cells cultured in the presence of testosterone. Likewise, cyclin D1-associated kinase activity did not change at 24 h, but decreased modestly at 48 h and substantially at 72 h following androgen depletion ( Figure 3a) .
In order to see if the suppression of cyclin D1/Cdk4 activities was due to alterations in the levels of individual cyclin and/or Cdk subunits, the eects of androgen depletion on the levels of the proteins were examined by Western analysis. As shown in Figure 3b , the level of Cdk4 protein remained unchanged after testosterone withdrawal. The level of cyclin D1 did not change, either, at 24 h, but decreased substantially at 48 h and remained reduced at 72 h after testosterone withdrawal ( Figure 3b ). Two closely migrating bands of cyclin D1 protein at approximately 36 kDa were observed, possibly due to a dierence in phosphorylation status (Matsushime et al., 1991) , and androgen depletion appeared to reduce the intensity of both bands.
We also examined alterations in the assembly of cyclin D1 and Cdk4 after androgen depletion. Lysates from SC-3 cells cultured with or without 10 77 M testosterone for various time periods were immunoprecipitated with anti-Cdk4 antibody, and the level of cyclin D1 in the immunoprecipitates was determined by Western analysis. The results in Figure 3c show that the amount of Cdk4-associated cyclin D1 clearly decreased at 48 ± 72 h after testosterone depletion, which is consistent with the results of the Western analysis ( Figure 3b ). Thus, it is conceivable that the decline in cyclin D1/Cdk4 complexes at 48 ± 72 h after androgen depletion accounts for the decrease in kinase activity observed at those times. It is to be noted, however, that although the decline in cyclin D1/Cdk4 activity was not evident until 48 h after androgen depletion, the eects on cell cycle arrest ( Figure 2) were already apparent at 24 h, suggesting that the decline in cyclin D1/Cdk4 activity may not be the cause of the cell cycle arrest.
Androgen-regulated cell growth in cyclin D1-transfected SC-3 cells
In order to determine the role of cyclin D1 in androgen-regulated growth of SC-3 cells, we prepared SC-3 sublines stably transfected with cyclin D1-expressing vectors and examined their response to androgen depletion. Western analysis con®rmed that in control cells transfected with empty vector the level of cyclin D1 protein decreased substantially at 72 h after testosterone depletion, while in SC-3 cells transfected with cyclin D1-expressing vector cyclin D1 was constitutively expressed and did not respond to hormone withdrawal (Figure 4b ). FACS analysis (Figure 4a ) clearly showed that in the absence of testosterone, G1 arrest occurred in SC-3 cells which constitutively expressed cyclin D1 as well as in control cells, suggesting that constitutive expression of cyclin D1 cannot prevent growth suppression following androgen depletion. Taken together with our results that the decline in cyclin D1 and the resultant inactivation of cyclin D1/Cdk4 (48 ± 72 h) do not precede the G1 arrest (24 h), these results lend further support to our concept that the decline in cyclin D1/ Cdk4 activity may not be the cause of the cell cycle arrest, and raise the possibility that there exists an alternative pathway causing G1 arrest following androgen depletion. 
Suppression of Cdk2 activity after androgen depletion
The time course and magnitude of the eect of androgen depletion on Cdk2 activity was dierent from those on Cdk4 activity. As shown in Figure 5a , Cdk2 activity markedly decreased as early as 24 h after androgen depletion of SC-3 cells, and was almost undetectable after 72 h. When cyclin E-and cyclin Aassociated kinase activities were determined following immunoprecipitation with speci®c antibodies, a signi®cant decline in both kinase activities was also observed after 24 h (Figure 5a ). These results suggest that the decline of cyclin E and A/Cdk2 activities plays a causative role in G1 arrest following androgen depletion.
When the levels of Cdk2 and cyclin subunits in cells cultured with or without testosterone were determined by Western analysis, no changes were observed in Cdk2 or cyclin E during the experimental period, and the amount of cyclin A decreased only slightly at 48 and 72 h (Figure 5b ). The amounts of cyclin E or cyclin A in the Cdk2 complexes were further examined by immunoprecipitation with anti-Cdk2 antibody followed by Western analysis using speci®c antibodies. In agreement with the results of the Western analysis, the amount of cyclin E complexed with Cdk2 remained unchanged throughout the experimental period, and the level of cyclin A in association with Cdk2 decreased only slightly at 48 ± 72 h (Figure 5c ). Taken together with the results on the activity of cyclin D1/Cdk4 complexes (Figure 3) , it seems more likely that the G1 arrest of SC-3 cells in response to androgen depletion is due to the profound inhibition of Cdk2 activity seen at 24 h rather than the less marked reduction in cyclin D1/Cdk4 activity which was observed only after 48 ± 72 h (Figure 3a) . Furthermore, the apparent lack of any alterations in cyclin E and cyclin A levels until 48 h cannot explain the suppression of Cdk2 activity as early as 24 h (Figure 5a ), raising the possibility that some other regulatory factor(s), such as CKIs, may be involved in the inactivation of Cdk2.
Induction of p27
Kip1 and its association with Cdk2 complexes following androgen depletion
In an attempt to identify a putative regulatory factor(s) responsible for the marked inhibition of Cdk2 activity concomitant with fairly constant amounts of Cdk2, cyclin E and cyclin A, we examined the mRNA levels of various CKIs by Northern blot analysis. As shown in Figure 6a , the level of p27
Kip1 mRNA was markedly increased as early as 24 h after SC-3 cells were cultured without testosterone and remained elevated until 72 h. In contrast, the level of p21
Waf1/Cip1/Sdi1 mRNA decreased after hormone depletion (Figure 6a) , and p57 Kip2 mRNA was hardly detectable in SC-3 cells (data not shown).
In agreement with the results of the Northern analysis, the Western analysis shown in Figure 6b revealed that the level of p27
Kip1 protein was elevated at 24 h and progressively increased until 72 h after testosterone withdrawal. p21
Waf1/Cip1/Sdi1 protein was barely detectable in SC-3 cells (data not shown). These results prompted us to hypothesize that the increased p27
Kip1 in response to androgen depletion becomes associated with Cdk2, leading to the inhibition of the kinase activity. To prove this, we examined the interaction between p27
Kip1 and Cdk2 in SC-3 cells cultured in the presence or absence of testosterone for various times. Cell lysates were immunoprecipitated with anti-Cdk2 antibody, and the amount of p27 Kip1 in the immunoprecipitates was quantitated by Western analysis using a monoclonal antibody to mouse p27
Kip1 . As shown in Figure 6c , the level of p27
Kip1 complexed with Cdk2 substantially increased as early as 24 h after testosterone depletion. These results suggest that the induction of p27 Kip1 following androgen withdrawal plays a pivotal role in the Cdk2 inactivation and the G1 arrest, through association with the kinase complex. In view of the relatively less dramatic increase in p27
Kip1 complexed with Cdk2 than the increase in p27
Kip1 mRNA and protein levels, it is possible that the amount of Cdk2 became rate-limiting as the level of p27
Kip1 exceeded that of Cdk2 following androgen depletion. 77 M testosterone for the indicated times, cell lysates were prepared and immunoprecipitated (IP) with either anti-Cdk4 or anti-cyclin D1 antibody. The kinase activities of the immunoprecipitates were determined using GSTRb as a substrate, as described in Materials and methods. (b) The amounts of Cdk4 and cyclin D1 proteins were quantitated by Western blot analysis using speci®c antibodies as described in Materials and methods. (c) Cell lysates were immunoprecipitated (IP) with anti-Cdk4 antibody, and the amounts of cyclin D1 in the immunoprecipitates were determined by Western blot analysis using a speci®c antibody against cyclin D1 p27 Kip1 in androgen-regulated cancer growth M Menjo et al
Discussion
The present study was undertaken to examine the sequence of events that occur in androgen-dependent mouse mammary carcinoma cells (SC-3) after hormone depletion. The experiments were designed to mimic the clinical situation in which hormone-dependent cancer growth is inhibited by anti-hormone therapy, with the perspective that elucidating the`normal' response of the cell cycle machinery might help us understand the mechanism(s) underlying the failure to maintain cell cycle arrest during continuous hormone depletion therapy. The results suggest that p27 Kip1 CKI is a critical target of androgen depletion and plays a key role in inhibiting Cdk2 activity through association with the kinase complex. Thus, disruption of these signaling pathways which uncouples cellular responses to hormonal environment, or adaptation of cancer cells to an androgen-depleted state may be involved in the progression to hormone-independent, advanced disease after continued anti-androgen therapy. However, it remains to be elucidated whether the link between androgen and p27 Kip1 is a generalized event and whether it actually operates in androgen-regulated growth of prostate cancer.
There is evidence that cyclin D1 plays an important role in estrogen-dependent growth of breast cancer as well as in the development of mammary glands (Wang et al., 1994; Sicinski et al., 1995; Fantl et al., 1995) . Overexpression of cyclin D1 in mouse mammary gland causes mammary hyperplasia and carcinoma (Wang et al., 1994) , and mice lacking cyclin D1 are defective in the full development of mammary glands (Sicinski et al., 1995; Fantl et al., 1995) . The cyclin D1 gene is ampli®ed and/or overexpressed in certain breast cancer patients (Buckley et al., 1993; Keyomarsi and Pardee, 1993) , and estrogen directly activates the transcription of the cyclin D1 gene in ER-positive breast carcinoma cells (Altucci et al., 1996) while growth suppression by antiestrogens is associated with reduction in cyclin D1 levels (Watts et al., 1995) . It is proposed that in ERpositive human breast cancer cells, estrogen increases cyclin D1, which causes activation of cyclin E/Cdk2 complexes through redistribution of p21 Waf1/Cip1/Sdi1 from cyclin E/Cdk2 to cyclin D1/Cdk4 complexes, with relatively constant levels of p21 Waf1/Cip1/Sdi1 and p27
Kip1
CKIs (Planas-Silva and Weinberg, 1997) . There is also evidence for a direct interaction between cyclin D1 and the hormone-binding domain of ER, which may underlie the hormone-independent activation of ER transcriptional function (Zwijsen et al., 1997; Neuman et al., 1997) . Taken together, it appears that cyclin D1 is a major target of estrogen-regulated breast cancer cell growth as well as hormone-independent tumor growth.
On the other hand, very little is known about the molecular mechanism underlying androgen-dependent cancer growth, especially with regard to a functional link between AR and the cell cycle machinery. Using an androgen-dependent prostate cancer cell line (LNCaP-FGC), it has been shown that androgen treatment leads to the upregulation of Cdk2 and Cdk4 genes with increased activity of Cdk2 (Lu et al., 1997) . We studied the cellular response to androgen depletion rather than to hormone stimulation in an androgen-dependent mammary carcinoma cell line Kip1 in androgen-regulated cancer growth M Menjo et al . Our data indicate that cyclin D1/Cdk4 activity substantially declines after androgen depletion, along with a decrease in cyclin D1 level, suggesting that the expression of cyclin D1 is controlled by androgen in this particular cancer cell line. However, the decline in the level of cyclin D1 is a later event (48 ± 72 h after androgen depletion) and cannot account for the earlier occurrence of cell cycle arrest (as early as 24 h). Together with our results showing that the constitutive expression of cyclin D1 fails to overcome the growth suppression in response to androgen depletion, it is suggested that an alternative pathway(s) causing G1 arrest exists. Detailed analysis of Cdk activities as well as measurements of the components of the kinase complexes revealed that up-regulation of p27
Kip1 CKI mRNA expression and its protein level, increased association of p27
Kip1 with Cdk2 complexes and the resultant suppression of Cdk2 activities play a critical role in cell cycle arrest following androgen depletion in SC-3 cells. It would be interesting to examine whether up-regulation of p27
Kip1 CKI after androgen depletion takes place in androgen-dependent prostate cancer cells.
In contrast to p27
, the mRNA expression of p21
Waf1/Cip1/Sdi1 , another member of the Cip/Kip family CKIs, was down-regulated following androgen depletion (Figure 6a ). Taken together with the accumulating evidence suggesting that the induction of p21
Waf1/Cip1/Sdi1 is associated with cell cycle progression/proliferation rather than cell cycle arrest (Macleod et al., 1995; Liu et al., 1996; Mantel et al., 1996) , it is possible that p21
Waf1/Cip1/Sdi1 is involved in androgen-mediated cell cycle progression in SC-3 cells. testosterone for the indicated times, cell lysates were prepared and immunoprecipitated (IP) with either anti-Cdk2, anti-cyclin E or anti-cyclin A antibody. The kinase activities of the immunoprecipitates were determined using histone H1 as a substrate, as described in Materials and methods. On shorter exposure, the bands were seen as doublets. (b) The amounts of Cdk2, cyclin E and cyclin A proteins were quantitated by Western blot analysis using speci®c antibodies. (c) Cell lysates were immunoprecipitated (IP) with anti-Cdk2 antibody, and the amounts of cyclin E and cyclin A in the immunoprecipitates were determined by Western blot analysis using speci®c antibodies Figure 6 Induction of p27
Kip1 and its association with Cdk2 complex following testosterone depletion in SC-3 cells. (a) After being cultured in the absence (7) or presence (+) of 10 77 M testosterone for the indicated times, total cellular RNA was prepared, and the levels of p27
Kip1 and p21 Waf1/Cip1/Sdi1 mRNA were determined by Northern blot analysis using 32 P-labeled cDNA probes. (b) Cell lysates were prepared, and the amounts of p27 Kip1 protein were quantitated by Western blot analysis using a speci®c antibody. (c) Cell lysates were immunoprecipitated with anti-Cdk2 antibody, and the amounts of p27
Kip1 in the immunoprecipitates were determined by Western blot analysis using a monoclonal antibody against mouse p27 Kip1 p27
Kip1 in androgen-regulated cancer growth M Menjo et al p27 Kip1 CKI plays a key role in G1 arrest following TGF-b treatment, contact inhibition, or serum/growth factor deprivation Coats et al., 1996) . However, TGF-b does not increase the level of p27 Kip1 , but causes redistribution of p27
Kip1 from cyclin D/Cdk4 to cyclin E/Cdk2 complexes, through the induction of p15
INK4b
, thereby inhibiting the kinase activity (ReynisdoÂ ttir et al., 1995) . Although cAMP or serum deprivation seems to increase the amount of p27
Kip1 protein (Coats et al., 1996; Kato et al., 1994) , post-translational ubiquitin-mediated proteasomal proteolysis has been implicated as a major mechanism in the regulation of p27
Kip1 protein levels (Hengst and Reed, 1996; Pagano et al., 1995) . Our results that both p27 Kip1 mRNA and protein levels increase after androgen depletion raise the possibility that the absence of androgen may directly or indirectly stimulate the transcription of the p27
Kip1 gene, or androgen itself represses the transcription through AR.
A variety of growth factors seem to act as mediators of steroid hormone-induced cell proliferation, most notably EGF, TGF-a and IGF-1 in estrogen-stimulated growth of breast cancer cells (Dickson and Lippman, 1987) . The involvement of an autocrine growth factor was also postulated for the androgenmediated growth of Shionogi tumors, and the putative androgen-induced growth factor (AIGF) was puri®ed from the conditioned medium of SC-3 cells treated with testosterone. cDNA cloning of AIGF revealed that it belongs to the FGF family and has been named FGF-8 (Tanaka et al., 1992) . Thus, it remains to be clari®ed whether the changes in p27
Kip1 gene expression we observed in androgen-responsive SC-3 cells result from direct action of AR on the regulatory region of the gene or from indirect eects through the FGF-8/ FGF receptor system.
It has recently been demonstrated that decreased expression of p27
Kip1 correlates with shorter diseasefree survival and/or poor overall survival in cohorts of patients with breast and colorectal cancer (Porter et al., 1997; Catzavelos et al., 1997; Loda et al., 1997) , that the level of p27
Kip1 is a more reliable predictor of the prognosis of these patients than histological grades or absence of p53 protein (Porter et al., 1997) , and that low p27
Kip1 levels re¯ect a high activity of p27
Kip1 degradation in tumors (Loda et al., 1997) . Since poor prognosis in patients with hormone-responsive carcinoma is generally taken as a sign of progression to an advanced disease resistant to endocrine therapy (Catalona, 1994) and since our current results suggest that p27 Kip1 may be a critical target of hormone depletion, it is tempting to speculate that the level of p27
Kip1 in tumors may be a determinant of hormone dependency; a low p27 Kip1 level in tumors means reduced responsiveness to anti-hormone therapy, leading to poor prognosis. The recent reports that mice lacking functional p27 Kip1 exhibit prostate hypertrophy (Nakayama et al., 1996) are also consistent with our hypothesis that p27 Kip1 is involved in the growth control of the prostate gland. Thus, it would be of interest to determine whether the level of p27 Kip1 in tumors correlates with androgen-responsiveness and/or overall prognosis of patients with prostate cancer.
Materials and methods

Antibodies
Polyclonal antibodies against human cyclin D1 (H-295), rat cyclin E (M-20), mouse cyclin A (C-19), human Cdk2 (M2), human Cdk4 (H-22) and mouse p27
Kip1 (M-197) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Monoclonal antibody against mouse p27
Kip1 was a kind gift from Dr H Matsushime (Nippon Roche Research Center, Kanagawa, Japan).
Cell culture
SC-3 cells, kindly provided by Dr Y Nishizawa (The Center for Adult Diseases, Osaka) and Dr K Matsumoto (Osaka Medical Center for Maternal and Child Health, Osaka, Japan), were maintained in minimum essential medium (MEM; Gibco BRL, Life Technologies, Inc., Grand Island, NY, USA) with 2% dextran-coated charcoal-treated fetal bovine serum (JRH Biosciences, Lenexa, KS, USA) and 10 77 M testosterone (Katayama Chemical Co., Osaka, Japan). For experiments, SC-3 cells were plated at a density of 2610 3 /cm 2 in the maintenance medium, and medium was changed to serum-free Dulbecco's modi®ed eagle medium (DMEM)/F12 (Gibco BRL, Life Technologies, Inc.) with 0.1% bovine serum albumin (Sigma Chemical Co., St. Louis, MO, USA) and 10 77 M testosterone on the following day. Two days later (at day 0), the medium was changed to serum-free DMEM/F12 with or without 10 77 M testosterone. Thereafter medium was changed with or without testosterone every other day. Viable cells were counted by trypan blue exclusion using a hemocytometer.
Cell cycle analysis
After being cultured in the presence or absence of 10 77 M testosterone for the indicated times, SC-3 cells were washed with chilled PBS and kept on ice in PBS containing 2 mM EDTA (Sigma Chemical Co.) for 10 min. Cells were collected using a cell scraper, suspended in PBS, and ®xed with 0.25% paraformaldehyde (Sigma Chemical Co.). Fixed cells were washed once with PBS, incubated with 100 mg of RNase A (Sigma Chemical Co.) in PBS containing 0.2% Tween 20, and stained with 50 mg/ml of propidium iodide (Sigma Chemical Co.). Cell cycle analysis was performed with a FACS Calibur¯ow cytometer (Becton Dickinson, Mans®eld, MA, USA). The percentage of cells in the G0/G1, S and G2/M phases of the cell cycle was determined using the Mod®t LT software program (Verity Software House Inc., Topsham, ME, USA).
Preparation of cell extracts and immunoprecipitation
After being cultured in the presence or absence of 10 77 M testosterone for the indicated times, SC-3 cells were lysed in immunoprecipitation (IP)-kinase buer containing 150 mM NaCl, 2.5 mM EGTA, 1 mM EDTA, 0.1% Tween 20, 10% glycerol and 50 mM HEPES, pH 8.0, supplemented with cocktails of protease inhibitors (2 mg/ml of leupeptin, 100 mg/ml of PMSF, 2 mg/ml of aprotinin and 20 mg/ml of trypsin inhibitor) and phosphatase inhibitors (10 mg/ml of b-glycerophosphate, 0.1 mM Na 3 VO 4 and 1 mM NaF). Cell lysates were assayed for protein concentration by Bradford analysis (Bio-rad Laboratories, Richmond, CA, USA), and equal amounts of proteins were used for immunoprecipitation or Western blot analyses.
For immunoprecipitation, cell lysates were incubated for 1 h with antibody at 48C with rocking and then with protein A agarose beads (Boehringer Mannheim, Mannheim, Kip1 in androgen-regulated cancer growth M Menjo et al Germany) for additional 1 h at 48C. Precipitates were collected by brief centrifugation.
Kinase assay
After immunoprecipitation, the precipitates were washed 4 times with IP kinase buer. For Rb phosphorylation, the immunoprecipitates were incubated at 308C for 30 min with a kinase buer containing 0.2 mg GST-Rb protein, 10 mM MgCl 2 , 50 mM HEPES, pH 8.0, 2.5 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2 mg/ml of aprotinin, 10 mM bglycerophosphate, 0.1 mM Na 3 VO 4 , 1 mM NaF, 10 mM ATP, and 185 KBq of [g-32 P] ATP (222 TBq/mmol; New England Nuclear, Boston, MA, USA). For histone H1 phosphorylation, the immunoprecipitates were incubated with a kinase buer containing 2.5 mg histone H1 protein (Boehringer Mannheim), 10 mM MgCl 2 , 50 mM HEPES, pH 8.0, 2.5 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2 mg/ ml of aprotinin, 10 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 1 mM NaF, 10 mM ATP, and 185 KBq of [g-32 P] ATP. The reaction mixture was electrophoresed in SDS ± 12% polyacrylamide gels, and the proteins were visualized by autoradiography.
Western blot analysis
Cell lysates in IP kinase buer were fractionated in SDS ± 12% polyacrylamide gels and transferred to nitrocellulose membranes (Amersham International plc., Little Chalfont, UK). For IP-Western blot analysis, the immunoprecipitates were washed four times with IP kinase buer, and fractionated in the same SDS ± polyacrylamide gels. Amounts of proteins were detected with an ECL system (Amersham International plc), following incubation with speci®c antibodies.
Northern blot analysis
Total cellular RNA was extracted from SC-3 cells using RNA isolation reagent (Isogen, Nippon Gene Co., Tokyo, Japan) according to the manufacturer's instructions. Total RNA (20 mg each) was denatured, size-fractionated on 1% agarose formaldehyde gels and transferred to nylon membranes (Micron Separations Inc., Westborough, MA, USA). p27
Kip1 , p21 Waf1/Cip1/Sdi1 , and p57 Kip2 cDNAs were labeled with [a- 32 P] dCTP (222 TBq/mmol; New England Nuclear) using the multiprime DNA labeling system (Amersham International plc), and hybridization was carried out in 50% formamide at 428C for 24 h.
Transfection with a cyclin D1 expression vector
The expression vector for cyclin D1 was constructed by subcloning 1.3 kb mouse cyclin D1 cDNA into the EcoRI site of pcDNA3 (Invitrogen Co., Carlsbad, CA, USA). SC-3 cells were transfected with the expression vector (25 mg) using the calcium phosphate precipitation technique, and clones resistant to 1 mg/ml of G418 (Gibco BRL, Life Technologies, Inc) were selected 3 weeks after the transfection.
Abbreviations ER, estrogen receptor; AR, androgen receptor; HEPES, N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid; PMSF, phenylmethylsulfonyl¯uoride.
